Literature DB >> 21283974

Budd-Chiari syndrome with fresh inferior vena cava thrombosis: agitation thrombolysis and balloon dilation.

P-X Ding1, Y-D Li, X-W Han, G Wu, S-F Shui, Y-L Wang.   

Abstract

BACKGROUND: To evaluate retrospectively our initial clinical experience of agitation thrombolysis and balloon dilation in the treatment of Budd-Chiari syndrome (BCS) in patients with fresh inferior vena cava (IVC) thrombosis. PATIENTS AND METHODS: Between August 2004 and March 2009, a total of 12 BCS patients with fresh IVC thrombosis were treated with agitation thrombolysis and balloon dilation. Color Doppler ultrasound results, as well as mortality, morbidity, and the clinical outcomes were evaluated immediately after the treatment and at one week and 1, 3, 6, 12 months after the procedure and then annually thereafter.
RESULTS: Agitation thrombolysis and balloon dilation were technically successful in all patients, without immediate procedural complications. The inferior vena cavagrams after the procedure demonstrated complete resolution of the IVC thrombi without pulmonary embolism and full patency of the obstructed IVC. Thirty-day mortality was nil. Clinical success was observed in all patients respectively one month after the procedure. As of February 2010, the mean (± SD) follow-up period for the color Doppler ultrasound procedure was 21.7 ± 8.9 months (range, 12 - 32 months). All patients showed complete patency of the treated IVC without thrombosis, restenosis, or reobstruction, and all patients are alive with resolution of the symptoms at the time of this report.
CONCLUSIONS: Our preliminary results suggest that agitation thrombolysis and balloon dilation may be a feasible approach for patients with BCS and fresh IVC thrombosis. However, larger studies are warranted to confirm these results.

Entities:  

Mesh:

Year:  2011        PMID: 21283974     DOI: 10.1024/0301-1526/a000070

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  5 in total

1.  Agitation thrombolysis and catheter-directed thrombolysis for normotensive patients with acute pulmonary thromboembolism.

Authors:  Yonghua Bi; Zepeng Yu; Xinwei Han; Jianzhuang Ren
Journal:  Radiol Med       Date:  2018-01-02       Impact factor: 3.469

2.  Evaluation of dangerous collateral vessels and thrombus in Budd-Chiari syndrome patients with inferior vena cava obstruction.

Authors:  Dehan Liu; Qianqian Ren; Tianhe Ye; Chuansheng Zheng; Yangbo Su; Xiangwen Xia
Journal:  Abdom Radiol (NY)       Date:  2021-12-09

3.  Excellent long-term outcomes of endovascular treatment in budd-chiari syndrome with hepatic veins involvement: A STROBE-compliant article.

Authors:  Yonghua Bi; Hongmei Chen; Pengxu Ding; Pengli Zhou; Xinwei Han; Jianzhuang Ren
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

4.  Treatment of Budd-Chiari syndrome with inferior vena cava thrombosis.

Authors:  Ruihua Wang; Qingyi Meng; Lifeng Qu; Xuejun Wu; Nianfeng Sun; Xing Jin
Journal:  Exp Ther Med       Date:  2013-02-18       Impact factor: 2.447

5.  Establishing a jugular-femoral venous route for recanalization of complicated inferior vena cava in Budd-Chiari Syndrome after transfemoral access failure.

Authors:  Yonghua Bi; Zhengyang Wu; Mengfei Yi; Xinwei Han; Jianzhuang Ren
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.